HIA
FLGT icon

Harbor Investment Advisory’s Fulgent Genetics FLGT Stock Holding History

Harbor Investment Advisory’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-90
Closed -$2.6K – 1338
2023
Q4 		$2.6K Hold
90
– – ﹤0.01% 1022
2023
Q3 		$2.41K Buy
+90
New +$3.07K ﹤0.01% 1022

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Harbor Investment Advisory's FLGT Position: Q1 2024 in Review

Harbor Investment Advisory sold out of Fulgent Genetics (FLGT) in Q1 2024, closing a stake of 90 shares — an estimated $2.6K sold.

Harbor Investment Advisory first reported a position in FLGT in Q3 2023 and held it in 2 quarters. The position peaked at $2.6K in Q4 2023. 180 funds tracked by Wall St. Rank hold FLGT as of Q1 2024.

  • Harbor Investment Advisory reported no remaining Fulgent Genetics position as of Q1 2024 after selling out during the quarter.
  • Harbor Investment Advisory sold 90 Fulgent Genetics shares in Q1 2024, an estimated $2.6K.
  • Harbor Investment Advisory first reported a position in Fulgent Genetics in Q3 2023 and held it in 2 quarters.
  • Harbor Investment Advisory's Fulgent Genetics position peaked at $2.6K in Q4 2023.
  • 180 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2024.

Based on Harbor Investment Advisory's 13F filing for Q1 2024, filed 12 Apr 2024.